Scolaris Content Display Scolaris Content Display

Daclizumab for relapsing remitting multiple sclerosis

Esta versión no es la más reciente

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:

To assess the efficacy and safety of daclizumab for patients with relapsing remitting multiple sclerosis.